Ernexa Therapeutics (ERNAW) Receivables (2010 - 2021)
Ernexa Therapeutics (ERNAW) reported Receivables of $1.4 million for Q4 2021, up 1121.43% on a YoY basis from $112000.0 in Q4 2020, and up 5390.01% quarter-over-quarter from $24918.0 in Q1 2021.
Ernexa Therapeutics (ERNAW) Receivables (2010 - 2021) Analysis & Trends
Ernexa Therapeutics has reported Receivables for 12 years, with the latest figure at $1.4 million in Q4 2021.
- For the quarter ending Q4 2021, Receivables rose 1121.43% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2021 stood at $1.4 million (up 1121.43% YoY), and the FY2021 full-year result was $1.4 million, up 1121.43% from the prior year.
- Receivables for Q4 2021 stood at $1.4 million, up from $24918.0 in the prior quarter.
- The five-year high for Receivables was $1.8 million in Q1 2017, with the low at $24918.0 in Q1 2021.
- Historically, Receivables has averaged $805936.4 across 5 years, with a median of $761000.0 in 2017.
- The largest YoY upside for Receivables was 1121.43% in 2021 against a maximum downside of 93.49% in 2021.
- Ernexa Therapeutics' Receivables stood at $714000.0 in 2017, then surged by 137.39% to $1.7 million in 2018, then slipped by 20.18% to $1.4 million in 2019, then plunged by 91.72% to $112000.0 in 2020, then surged by 1121.43% to $1.4 million in 2021.
- The last three Receivables figures came in at $1.4 million (Q4 2021), $24918.0 (Q1 2021), and $112000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.37 Mn |
| Mar 31, 2021 | 24,918.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 132,000.00 |
| Mar 31, 2020 | 383,000.00 |
| Dec 31, 2019 | 1.35 Mn |
| Sep 30, 2019 | 777,000.00 |
| Jun 30, 2019 | 732,000.00 |
| Mar 31, 2019 | 158,000.00 |
| Dec 31, 2018 | 1.70 Mn |
| Sep 30, 2018 | 1.28 Mn |
| Jun 30, 2018 | 787,000.00 |
| Mar 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | 714,000.00 |
| Sep 30, 2017 | 627,000.00 |
| Jun 30, 2017 | 761,000.00 |
| Mar 31, 2017 | 1.77 Mn |
| Dec 31, 2016 | 928,000.00 |
| Sep 30, 2016 | 898,000.00 |
| Jun 30, 2016 | 641,000.00 |